D.E. Shaw & Co’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21M | Sell |
200,764
-346,901
| -63% | -$36.2M | 0.01% | 688 |
|
|
2025
Q1 | $63.9M | Buy |
547,665
+527,319
| +2,592% | +$61.5M | 0.06% | 279 |
|
|
2024
Q4 | $1.72M | Buy |
20,346
+17,446
| +602% | +$1.48M | ﹤0.01% | 1873 |
|
|
2024
Q3 | $261K | Sell |
2,900
-3,434
| -54% | -$309K | ﹤0.01% | 2737 |
|
|
2024
Q2 | $510K | Sell |
6,334
-1,435
| -18% | -$116K | ﹤0.01% | 2480 |
|
|
2024
Q1 | $620K | Sell |
7,769
-1,415
| -15% | -$113K | ﹤0.01% | 2329 |
|
|
2023
Q4 | $731K | Buy |
+9,184
| New | +$731K | ﹤0.01% | 2219 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 3054 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 3088 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 3307 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 3602 |
|
|
2022
Q3 | – | Sell |
-6,762
| Closed | -$259K | – | 3889 |
|
|
2022
Q2 | $259K | Sell |
6,762
-148,630
| -96% | -$5.69M | ﹤0.01% | 3287 |
|
|
2022
Q1 | $6.43M | Buy |
+155,392
| New | +$6.43M | 0.01% | 1457 |
|
|
2021
Q4 | – | Sell |
-13,939
| Closed | -$459K | – | 3974 |
|
|
2021
Q3 | $459K | Sell |
13,939
-9,110
| -40% | -$300K | ﹤0.01% | 2884 |
|
|
2021
Q2 | $1.56M | Sell |
23,049
-10,169
| -31% | -$686K | ﹤0.01% | 2246 |
|
|
2021
Q1 | $1.88M | Sell |
33,218
-133,964
| -80% | -$7.58M | ﹤0.01% | 1884 |
|
|
2020
Q4 | $13.6M | Sell |
167,182
-64,060
| -28% | -$5.22M | 0.01% | 849 |
|
|
2020
Q3 | $16.5M | Sell |
231,242
-4,461
| -2% | -$318K | 0.02% | 690 |
|
|
2020
Q2 | $19.4M | Sell |
235,703
-122,992
| -34% | -$10.1M | 0.02% | 586 |
|
|
2020
Q1 | $21.1M | Buy |
358,695
+275,232
| +330% | +$16.2M | 0.03% | 460 |
|
|
2019
Q4 | $8.63M | Sell |
83,463
-36,488
| -30% | -$3.77M | 0.01% | 914 |
|
|
2019
Q3 | $2.43M | Buy |
119,951
+85,195
| +245% | +$1.72M | ﹤0.01% | 1486 |
|
|
2019
Q2 | $895K | Buy |
+34,756
| New | +$895K | ﹤0.01% | 1920 |
|